Trends in incidence and mortality risk for acromegaly in Norway: a cohort study.
Camilla M FalchNicoleta C OlarescuJens BollerslevOlaf M DekkersAnsgar HeckPublished in: Endocrine (2022)
In this large cohort study, covering the period 1999-2019, patients were treated with individualized multimodal management. Mortality was not increased compared to the general population and comparable with recent registry studies from the Nordic countries and Europe. Overall cancer risk was slightly, but not significantly increased in the patients.